Analyst consensus rating
Merck Analyst Rating: Buy
Direct answer
Merck's consensus rating is Buy.
26 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $161.53.
Forecast evidence checked November 4, 2026.
Get free Merck email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $144.67
- Average price target
- $161.53
- High price target
- $186.00
- Low price target
- $105.00
- Low target gap
- -27.4%
- Target upside
- +11.7%
- High target gap
- +28.6%
- Target range width
- 56%
- Consensus rating
- Buy
- Analysts
- 26
- Evidence date
- November 4, 2026
- Valid through
- November 11, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Merck?
Merck has a verified Buy consensus. The same dataset has an average price target of $161.53.
How far are Merck's low and high targets from the recorded price?
The low target implies -27.4%, while the high target implies +28.6%.
How many analysts are included in Merck's consensus?
The verified consensus includes 26 analysts.
How is Merck's target upside or downside calculated?
The average target of $161.53 is divided by the recorded price of $144.67, then one is subtracted to produce +11.7%. This does not guarantee a future return.
When was Merck's analyst forecast verified?
The data was verified on 2026-11-04. The dataset is valid through 2026-11-11.